GlobeNewswire

Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress
12/11/2026
Initiated the Company’s third Phase 1b clinical trial, BActinium-2, broadening the evaluation of AKY-2519 to lung cancer and other B7-H3 expressing tumors Started first backfill cohorts in the ongoing Phase 1b NECTINIUM [...]
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results
12/11/2026
BLA submission for miv-cel in SPS completed with request for priority review Commercial readiness advancing for potential U.S. launch of miv-cel, which would become the first approved therapy for SPS and first approved [...]
Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
12/11/2026
WILMETTE, Ill., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with [...]
CollPlant to Begin Trading on Nasdaq Under New Ticker Symbol “OPHI”
12/11/2026
OPHI marks another important step in CollPlant’s strategy to expand and focus its operations built around LightSolver’s all-optical Laser Processing Unit (LPU)™ Rehovot, Israel, Nov. 12, 2026 (GLOBE NEWSWIRE) -- [...]
IMUNON Reports Third Quarter 2026 Financial Results and Provides Business Update
12/11/2026
IMNN-001 is the first frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with ovarian cancer Enrollment in the Phase 3 OVATION 3 [...]
Randomized Study of Non-Invasive Autonomic Neuromodulation for Long COVID Published Online in Neuromodulation
12/11/2026
Randomized, open-label, hypothesis-generating study (541 participants enrolled; 250 met final analysis criteria) evaluated two proprietary non-invasive neuromodulation technologies, electroCore’s cervical vagus nerve [...]
Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
12/11/2026
– VIRAGE2 enrollment expected to complete in Q4 2026; initial data expected by Q3 2027 – – Company completes sale of SYN-004 (ribaxamase) and related portfolio of antibiotic-degrading enzymes to Biossil Labs Inc. in [...]
Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED
12/11/2026
ALLIS MED to lead regulatory certification process and serve as exclusive distributor for Baird Medical Microwave Ablation (MWA) products in key market NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Baird Medical [...]
Evaxion announce 2027 financial calendar
12/11/2026
COPENHAGEN, Denmark, November 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces its financial [...]
Axiom Biosciences Announces Regulation Crowdfunding Offering With Wefunder Community Round
12/11/2026
Regulation Crowdfunding offering provides retail investor access to Axiom’s clinical-stage biotechnology platform SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Axiom Biosciences , a clinical-stage biotechnology company [...]
CytoDyn Announces $5 Million Private Investment to Advance Leronlimab in Colorectal Cancer and Other Solid Tumors
12/11/2026
VANCOUVER, Washington, Nov. 12, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody [...]
Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026
12/11/2026
Microchip-enabled sensing platform aims to combine signal acquisition, mapping and real-time catheter positioning to support future nerve-targeted procedures THE WOODLANDS, TX, Nov. 12, 2026 (GLOBE NEWSWIRE) -- [...]
Sol-Gel Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
12/11/2026
Pivotal Phase 3 trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome reached last patient last visit in September 2026, with 102 of 113 enrolled patients completing the study; top-line results expected in late [...]
Alpha Tau to Host Investor Call to Review New Data from the Alpha DaRT® Recurrent Glioblastoma REGAIN Trial
12/11/2026
– Call to Follow Presentation of New Data at Upcoming Society for Neuro-Oncology SNO Conference – JERUSALEM, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq/TASE: DRTS, DRTSW) (“Alpha Tau”), the [...]
Moleculin Secures Australian Patent for Annamycin Formulation Technology
12/11/2026
Patent strengthens intellectual property protection for preparation of preliposomal Annamycin lyophilizate HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq: MBRX) (“Moleculin” or the “Company [...]
HOLLYWOOD HAS THE FANS. WHO BUILDS THE BUSINESS?
12/11/2026
BOSTON, MA, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Vystar Corporation (OTCQB: VYST) today announced that for decades, movie investing was largely reserved for studios, financiers and wealthy individuals willing to gamble on [...]
Alps Group Inc Launches Pharmaco-Interaction (PCI) Unit via MyGenome, Debuting with CYP450 Drug Interaction Testing
12/11/2026
PCI Positions MyGenome as Southeast Asia's Reference Laboratory for Drug Interaction Safety Science KUALA LUMPUR, Malaysia, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Alps Group Inc (“Alps” or “the Company”) (Nasdaq: ALPS), an [...]
Medicana Expert Highlights: New Study Finds Better One-Year Outcomes After Robot-Assisted Knee Replacement
12/11/2026
The research involving 845 patients found improvements in pain, knee function and patient satisfaction, drawing attention to the role of personalised surgical planning in joint replacement ISTANBUL, Nov. 12, 2026 (GLOBE [...]
Olympia Pharmaceuticals to Compound Select Peptides Under HHS Interim Enforcement Policy
12/11/2026
503A pharmacy will begin compounding BPC-157, with plans to expand across eligible peptides ORLANDO, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a premier FDA-registered 503B outsourcing facility [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum